• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国乳腺癌服务筛查计划中筛查性乳房 X 光检查召回率与间隔期癌症之间的关联:一项队列研究。

Association between Screening Mammography Recall Rate and Interval Cancers in the UK Breast Cancer Service Screening Program: A Cohort Study.

机构信息

From the Department of Radiology, University of Wisconsin School of Medicine and Public Health, E3/311 Clinical Science Center, 600 Highland Ave, Madison, WI 53792-3252 (E.S.B.); Centre for Cancer Prevention, Queen Mary University of London, Wolfson Institute of Preventive Medicine, London, England (D.V., S.W.D.); and Nuffield Department of Population Health, University of Oxford, Oxford, England (R.G.B.).

出版信息

Radiology. 2018 Jul;288(1):47-54. doi: 10.1148/radiol.2018171539. Epub 2018 Apr 3.

DOI:10.1148/radiol.2018171539
PMID:29613846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6027996/
Abstract

Purpose To determine whether low levels of recall lead to increased interval cancers and the magnitude of this effect. Materials and Methods The authors retrospectively analyzed prospectively collected data from the UK National Health Service Breast Screening Programme during a 36-month period (April 1, 2005 to March 31, 2008), with 3-year follow-up in women aged 50-70 years. Data on recall, cancers detected at screening, and interval cancers were available for each of the 84 breast screening units and for each year (n = 252). The association between interval cancers and recalls was modeled by using Poisson regression on aggregated data and according to age (5-year intervals) and screening type (prevalent vs incident). Results The authors analyzed 5 126 689 screening episodes, demonstrating an average recall to assessment rate (RAR) of 4.56% (range, 1.64%-8.42%; standard deviation, 1.15%), cancer detection rate of 8.1 per 1000 women screened, and interval cancer rate (ICR) of 3.1 per 1000 women screened. Overall, a significant negative association was found between RAR and ICR (Poisson regression coefficient: -0.039 [95% confidence interval: -0.062, -0.017]; P = .001), with approximately one fewer interval cancer for every additional 80-84 recalls. Subgroup analysis revealed similar negative correlations in women aged 50-54 years (P = .002), 60-64 years (P = .01), and 65-69 years (P = .008) as well as in incident screens (P = .001) and prevalent screens (P = .04). No significant relationship was found in women aged 55-59 years (P = .46). Conclusion There was a statistically significant negative correlation between RAR and ICR, which suggests the merit of a minimum threshold for RAR. RSNA, 2018 Online supplemental material is available for this article.

摘要

目的

确定低召回率是否会导致间期癌的增加,以及这种影响的程度。

材料与方法

作者回顾性分析了英国国家卫生服务部乳房筛查计划在 36 个月期间(2005 年 4 月 1 日至 2008 年 3 月 31 日)收集的前瞻性数据,并对 50-70 岁女性进行了 3 年随访。每个乳房筛查单位和每年(n = 252)都有关于召回、筛查中检出的癌症和间期癌的数据。使用泊松回归对汇总数据进行分析,并根据年龄(5 年间隔)和筛查类型(现患 vs 新发病例),对间期癌与召回的关系进行建模。

结果

作者分析了 5126689 个筛查期,平均召回率为 4.56%(范围,1.64%-8.42%;标准差,1.15%),每 1000 名筛查女性的癌症检出率为 8.1 例,间期癌发生率为 3.1 例。总体而言,RAR 与 ICR 之间存在显著的负相关关系(泊松回归系数:-0.039 [95%置信区间:-0.062,-0.017];P =.001),每增加 80-84 次额外召回,就会减少约 1 例间期癌。亚组分析显示,在 50-54 岁(P =.002)、60-64 岁(P =.01)和 65-69 岁(P =.008)的女性以及新发病例(P =.001)和现患病例(P =.04)中也存在类似的负相关关系。在 55-59 岁的女性中,未发现显著的相关性(P =.46)。

结论

RAR 与 ICR 之间存在显著的负相关关系,这表明 RAR 的最低阈值是有意义的。RSNA,2018 年在线补充材料可供本文参考。

相似文献

1
Association between Screening Mammography Recall Rate and Interval Cancers in the UK Breast Cancer Service Screening Program: A Cohort Study.英国乳腺癌服务筛查计划中筛查性乳房 X 光检查召回率与间隔期癌症之间的关联:一项队列研究。
Radiology. 2018 Jul;288(1):47-54. doi: 10.1148/radiol.2018171539. Epub 2018 Apr 3.
2
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.从 40 岁开始每年进行乳腺 X 线筛查以降低女性乳腺癌死亡率:英国年龄 RCT 的长期随访。
Health Technol Assess. 2020 Oct;24(55):1-24. doi: 10.3310/hta24550.
3
A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one and two view mammography: results from the UK National Health Service breast screening programme.英国国家医疗服务体系乳腺癌筛查项目中,针对单视图和双视图乳腺钼靶检查,按阅片者数量比较乳腺癌检出率:结果报告
J Med Screen. 1998;5(4):195-201. doi: 10.1136/jms.5.4.195.
4
Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.补充乳腺磁共振成像筛查对乳腺癌平均风险女性。
Radiology. 2017 May;283(2):361-370. doi: 10.1148/radiol.2016161444. Epub 2017 Feb 21.
5
Five Consecutive Years of Screening with Digital Breast Tomosynthesis: Outcomes by Screening Year and Round.连续 5 年使用数字乳腺断层合成技术进行筛查:按筛查年度和轮次的结果。
Radiology. 2020 May;295(2):285-293. doi: 10.1148/radiol.2020191751. Epub 2020 Mar 10.
6
Impact of Digital Mammography on Cancer Detection and Recall Rates: 11.3 Million Screening Episodes in the English National Health Service Breast Cancer Screening Program.数字乳腺 X 线摄影对癌症检出率和召回率的影响:英国国家卫生服务体系乳腺癌筛查计划中的 1130 万次筛查。
Radiology. 2019 Mar;290(3):629-637. doi: 10.1148/radiol.2018181426. Epub 2018 Dec 11.
7
Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.评估接受筛查性乳腺磁共振成像的高风险女性进行筛查性乳房 X 光检查的效用。
Radiology. 2017 Oct;285(1):36-43. doi: 10.1148/radiol.2017161103. Epub 2017 Jun 6.
8
Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.导管原位癌的筛查检测及随后发生的浸润性间隔期乳腺癌:一项基于人群的回顾性研究。
Lancet Oncol. 2016 Jan;17(1):109-14. doi: 10.1016/S1470-2045(15)00446-5. Epub 2015 Dec 5.
9
Comparing the performance of mammography screening in the USA and the UK.比较美国和英国乳腺钼靶筛查的效果。
J Med Screen. 2005;12(1):50-4. doi: 10.1258/0969141053279130.
10
The Potential Impact of Digital Breast Tomosynthesis on the Benign Biopsy Rate in Women Recalled within the UK Breast Screening Programme.数字乳腺断层合成对英国乳腺筛查计划中召回女性良性活检率的潜在影响。
Radiology. 2019 May;291(2):310-317. doi: 10.1148/radiol.2019180809. Epub 2019 Mar 19.

引用本文的文献

1
Biennial Mammography Performance in the Korean National Cancer Screening Program From 2009 to 2020.2009年至2020年韩国国家癌症筛查计划中的两年一次乳房X线摄影检查情况
Korean J Radiol. 2025 Apr;26(4):313-323. doi: 10.3348/kjr.2024.0866. Epub 2025 Feb 20.
2
Optimising the diagnostic accuracy of First post-contrAst SubtracTed breast MRI (FAST MRI) through interpretation-training: a multicentre e-learning study, mapping the learning curve of NHS Breast Screening Programme (NHSBSP) mammogram readers using an enriched dataset.通过解读培训提高首剂对比后 subtracted 乳腺 MRI(FAST MRI)的诊断准确性:一项多中心电子学习研究,利用丰富数据集描绘 NHS 乳腺筛查计划(NHSBSP)乳腺 X 线摄影读者的学习曲线。
Breast Cancer Res. 2024 May 28;26(1):85. doi: 10.1186/s13058-024-01846-1.
3
The influence of breast screening on breast cancer incidence in England: observational study based on cancer registries and bulletins of the NHS Breast Screening Programme.英国乳腺筛查对乳腺癌发病率的影响:基于癌症登记处和英国国家医疗服务体系乳腺筛查计划公告的观察性研究。
Eur J Public Health. 2024 Aug 1;34(4):812-817. doi: 10.1093/eurpub/ckae069.
4
The cost-effectiveness of risk-stratified breast cancer screening in the UK.英国风险分层乳腺癌筛查的成本效益。
Br J Cancer. 2023 Nov;129(11):1801-1809. doi: 10.1038/s41416-023-02461-1. Epub 2023 Oct 17.
5
Evaluation of breast cancer screening indicators in the female population using the National Health System, Brazil, 2018-2019: a descriptive study.利用巴西国家卫生系统评估 2018-2019 年女性人群的乳腺癌筛查指标:描述性研究。
Epidemiol Serv Saude. 2023 May 8;32(2):e2022567. doi: 10.1590/S2237-96222023000200009. eCollection 2023.
6
Test performance metrics for breast, cervical, colon, and lung cancer screening: a systematic review.用于乳腺癌、宫颈癌、结肠癌和肺癌筛查的检测性能指标:系统评价。
J Natl Cancer Inst. 2023 Apr 11;115(4):375-384. doi: 10.1093/jnci/djad028.
7
A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in England.一项在英格兰评估乳腺癌筛查计划对乳腺癌发病率影响的病例对照研究。
Cancer Med. 2023 Jan;12(2):1878-1887. doi: 10.1002/cam4.5004. Epub 2022 Jul 18.
8
Subsequent attendance in a breast cancer screening program after a false-positive result in the Local Health Authority of Bologna (Italy).在意大利博洛尼亚地方卫生局(意大利)的假阳性结果后,随后参加乳腺癌筛查计划。
Sci Rep. 2021 Apr 20;11(1):8530. doi: 10.1038/s41598-021-87864-x.
9
Association between radiologists' and facilities' characteristics and mammography screening detection of ductal carcinoma in situ.放射科医生和医疗机构特征与乳腺导管原位癌筛查检出率的相关性研究
Breast Cancer Res Treat. 2021 May;187(1):255-266. doi: 10.1007/s10549-020-06057-8. Epub 2021 Jan 4.
10
Magnetic Resonance Imaging in Screening of Breast Cancer.磁共振成像在乳腺癌筛查中的应用
Radiol Clin North Am. 2021 Jan;59(1):85-98. doi: 10.1016/j.rcl.2020.09.004. Epub 2020 Oct 29.

本文引用的文献

1
Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.欧洲乳腺影像学会(EUSOBI)以及来自奥地利、比利时、波斯尼亚和黑塞哥维那、保加利亚、克罗地亚、捷克共和国、丹麦、爱沙尼亚、芬兰、法国、德国、希腊、匈牙利、冰岛、爱尔兰、意大利、以色列、立陶宛、摩尔多瓦、荷兰、挪威、波兰、葡萄牙、罗马尼亚、塞尔维亚、斯洛伐克、西班牙、瑞典、瑞士和土耳其的30个国家乳腺放射学机构关于乳腺癌筛查的立场文件
Eur Radiol. 2017 Jul;27(7):2737-2743. doi: 10.1007/s00330-016-4612-z. Epub 2016 Nov 2.
2
Recall and Cancer Detection Rates for Screening Mammography: Finding the Sweet Spot.筛查性乳腺X线摄影的召回率和癌症检出率:寻找最佳平衡点。
AJR Am J Roentgenol. 2017 Jan;208(1):208-213. doi: 10.2214/AJR.15.15987. Epub 2016 Sep 28.
3
Breast cancer screening in England and the United States: a comparison of provision and utilisation.英格兰和美国的乳腺癌筛查:供给与利用情况比较
Int J Public Health. 2015 Dec;60(8):881-90. doi: 10.1007/s00038-015-0740-5. Epub 2015 Oct 7.
4
Socioeconomic inequalities in breast and cervical screening coverage in England: are we closing the gap?英格兰乳腺癌和宫颈癌筛查覆盖率中的社会经济不平等:我们正在缩小差距吗?
J Med Screen. 2016 Jun;23(2):98-103. doi: 10.1177/0969141315600192. Epub 2015 Sep 16.
5
Criteria for identifying radiologists with acceptable screening mammography interpretive performance on basis of multiple performance measures.基于多项性能指标确定具有可接受的乳腺钼靶筛查解读性能的放射科医生的标准。
AJR Am J Roentgenol. 2015 Apr;204(4):W486-91. doi: 10.2214/AJR.13.12313.
6
Addressing the challenge of assessing physician-level screening performance: mammography as an example.应对评估医生层面筛查表现的挑战:以乳腺钼靶检查为例。
PLoS One. 2014 Feb 21;9(2):e89418. doi: 10.1371/journal.pone.0089418. eCollection 2014.
7
Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme.英国乳房筛查计划引入双视图乳房 X 光摄影后,间隔期癌症发病率降低。
Br J Cancer. 2014 Feb 4;110(3):560-4. doi: 10.1038/bjc.2013.778. Epub 2013 Dec 24.
8
Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens.全国范围内数字化乳腺摄影过渡期间的筛查性能数据:600 万次筛查的观察结果。
Eur J Cancer. 2013 Nov;49(16):3517-25. doi: 10.1016/j.ejca.2013.06.020. Epub 2013 Jul 17.
9
Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland.英格兰、威尔士和北爱尔兰国民保健署乳腺癌筛查计划中的间期癌。
Br J Cancer. 2011 Feb 15;104(4):571-7. doi: 10.1038/bjc.2011.3. Epub 2011 Feb 1.
10
Identifying minimally acceptable interpretive performance criteria for screening mammography.确定可接受的筛查性乳房 X 光摄影术的最低解释性能标准。
Radiology. 2010 May;255(2):354-61. doi: 10.1148/radiol.10091636.